Roxythromycin reinforces epithelial defence function in rabbit trachea

Acta Oto-Laryngologica, Supplement

Volumn , Issue 538, 1998, Pages 233-238

  Nakano, Tomoaki ^a   Ohashi, Yoshihiro ^a   Tanaka, Ayaki ^a   Kakinoki, Yasushi ^a   Washio, Yushi ^a   Nakai, Yoshiaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ciliary activity; Epithelial permeability; Mucociliary transport velocity; Roxythromycin

Indexed keywords

DEXTRAN; ERYTHROMYCIN; ISOTHIOCYANIC ACID; ROXYTHROMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ROXITHROMYCIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BRONCHOSCOPY; IMAGE ANALYSIS; INFLAMMATORY DISEASE; MEMBRANE PERMEABILITY; MOLECULAR WEIGHT; MUCOCILIARY TRANSPORT; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SPECTROFLUOROMETRY; STATISTICAL ANALYSIS; VIDEORECORDING; ANIMAL; DRUG EFFECT; EPITHELIUM; EUKARYOTIC FLAGELLUM; IN VITRO STUDY; MUCOCILIARY CLEARANCE; PERMEABILITY; PHYSIOLOGY; TRACHEA;

ANIMALS; ANTI-BACTERIAL AGENTS; CILIA; EPITHELIUM; MUCOCILIARY CLEARANCE; PERMEABILITY; PLATELET ACTIVATING FACTOR; RABBITS; ROXITHROMYCIN; TRACHEA;

EID: 0031593529     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kudo S, Uetake T, Hagiwara K, et al. Clinical effect of long-term, low-dosage erythromycin chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis 1987; 25: 632-42.
2. Miyatake H, Taki F, Taniguchi H, et al. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 1991; 99: 670-3.
3. Minami T, Kubo N, Kumazawa H, et al. Long-term low-dosage roxythromycin therapy for chronic sinusitis: objective evaluation with x-ray mucociliary functional test. Pract Otol (Kyoto) 1995; 88: 1229-36.
4. Iino Y, Sugita K, Toriyama M, et al. Erythromycin therapy for otitis media with effusion in sinobronchial syndrome. Arch Otolaryngol Head Neck Surg 1993; 119: 648-51.
5. Okamoto H, Ohashi Y, Ohno Y, et al. Roxythromycin in the treatment of Japanese cedar pollen-induced allergic rhinitis. Pract Otol (Kyoto) 1994; 87: 1591-9.
6. Torre D, Broggini M, Botta V, et al. In vitro and ex vivo effects of recent and new macrolide antibiotics on chemotaxis of human polymorphonuclear leukocytes. J Chemother 1991; 3: 236-9.
7. Goswami SK, Kivity S, Marom Z. Erythromycin inhibits respiratory glycoconjugates secretion from human airways in vitro. Am Rev Respir Dis 1990; 141: 72-8.
8. Delaney SG, Taylor DR. Steroid-sparing agents in the treatment of asthma. Med J Aust 1992; 157: 437-9.
9. Ohashi Y, Nakai Y. Functional and morphological studies on chronic sinusitis mucous membrane. 2. Functional and morphological pathology of chronic sinusitis mucous membrane. Acta Otolaryngol (Stockh) 1993; Suppl 397: 10-49.
10. Ohashi Y, Nakai Y, Ikeoka H, Furuya H, Esaki Y, Kato S. Increased ciliary beating frequency of nasal mucosa following immunotherapy for allergy. Ann Otol Rhinol Laryngol 1989; 98: 350-4.
11. Tamaoki J, Chiyotani A, Sasaki N, et al. Effect of erythromycin on ciliary motility in rabbit airway epithelium in vitro. J Antimicrob Chemother 1992; 29: 173-8.
12. Ohashi Y, Nakai Y, Koshimo H, et al. Ciliary activity in the in vitro tubotympanum. Arch Otorhinolaryngol 1986; 243: 317-9.
13. Ohashi Y, Nakai Y. Reduced ciliary action in chronic sinusitis. Acta Otolaryngol (Stockh) 1983; Suppl 397: 3-9.
14. Ohashi Y, Nakai Y, Morimoto K, et al. Platelet activating factor compromises epithelial defence function in the airway. J Allergy Clin Immunol 1997; 100: 520-6.
15. Richardson J, Bouchard T, Ferguson CC. Uptake and transport of exogenous proteins by respiratory epithelium. Lab Invest 1976; 35: 307-14.
16. Boucher RC, Pare PD, Gilmore NJ, Moroz LA, Hogg JC. Airway mucosal permeability in the Ascaris suum-sensitive rhesus monkey. J Allergy Clin Immunol 1977; 60: 134-40.
17. Hulbert WC, Walker DC, Jackson A, Hogg JC. Air-way permeability to horseradish peroxidase in guinea pigs: repair phase after injury by cigarette smoke. Am Rev Respir Dis 1981; 123: 320-6.
18. Cerrina J, Ladurie LR, Labat C, et al. Comparison of human bronchial muscle response to histamine in vivo with histamine and isoproterenol agonists in vitro. Am Rev Respir Dis 1986; 134: 57-61.
19. Sparrow MP, Omari TI, Mitchell HW. The epithelial barrier and airway responsiveness. Can J Physiol Pharmacol 1995; 73: 180-90.
20. Wangensteen OD, Schneider LA, Fahrenkrug SC, et al. Tracheal epithelial permeability to non-electrolytes; species differences. J Appl Physiol 1993; 75: 1009-18.
21. Ohashi Y, Ohno Y, Sugiura Y, et al. Presence of bronchoalveolar lavage fluid necessary for platelet activating factor-induced ciliary depression. Int Arch Allergy Immunol 1994; 104: 302-6.
22. Ohashi Y, Nakai Y, Ohno Y, et al. The influence of allergic response on the ear. In: Honjo I, ed. The auditory system. Amsterdam: Kugler Publications, 1994: 15-25.
23. Ohashi Y, Nakai Y, Zushi K, et al. Enhancement of ciliary action by a β-adrenergic stimulant. Acta Otolaryngol (Stockh) 1983; Suppl 397: 49-59.
24. Ohashi Y, Nakai Y. Current concept of mucociliary dysfunction in otitis media with effusion. Acta Otolaryngol (Stockh) 1991; Suppl 486: 149-61.
25. Wanner A. Allergic mucociliary dysfunction. J. Allergy Clin Immunol 1983; 72: 347-50.
26. Elia C, Bucca C, Rolla G, Scappaticci E, Cantino D. Freeze fracture study of human bronchial epithelium in normal, bronchitic and asthmatic subjects. J Submicrosc Cytol 1988; 20: 509-17.
27. Ohashi Y, Nakai Y, Kihara S, Ikeoka H, Takano H, Imoto T. Ciliary activity in patients with nasal allergies. Arch Otorhinolaryngol 1985; 242: 141-7.